The Board of Directors of Suzhou Fushilai Pharmaceutical Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.68 CNY | -8.21% | +26.79% | +10.53% |
1st Jan change | Capi. | |
---|---|---|
+10.53% | 493M | |
+31.16% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.73% | 330B | |
+3.85% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.90% | 168B |
- Stock Market
- Equities
- 301258 Stock
- News Suzhou Fushilai Pharmaceutical Co., Ltd.
- Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.